The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of ...

Inspire is a hypoglossal nerve stimulator (HNS) to treat obstructive sleep apnea. It is an implantable device that stimulates nerves controlling the tongue.

THURSDAY, Sept. 14, 2017 -- People with more serious cases of sleep apnea may get lasting relief from an implanted nerve stimulator, a new study finds. One specialist says the device might benefit ...

The Inspire procedure is a hypoglossal nerve stimulator to replace CPAP machines for those with obstructive sleep apnea. The device is implanted surgically into the body and operated by remote ...

Improvements in respiratory measures and quality-of-life outcomes following hypoglossal nerve stimulation in patients with moderate to severe obstructive sleep apnea (OSA) are maintained for up to ...

It comes as UCLH became the first centre in the UK to offer sleep apnoea patients a choice of nerve stimulators – the Genio Nyxoah or the Inspire implant. Both devices stimulate the hypoglossal nerve, ...

nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its IV Implantable Pulse Generator (IPG) on June 17. The recall extends to 32 ...

Prior to having Inspire, her breathing would pause for 10 seconds or more about 65 times per hour each night. Anything over 30 is considered severe sleep apnoea.

The FDA has labeled a recall of Inspire Medical Systems, Inc.’s (NYSE:INSP) nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind. Inspire initiated a recall of its ...